https://hdac-assay.com/long-te....rm-follow-up-study-t
Furthermore, under experimental conditions, chimeric αDEC205 or αDCIR2 mAbs are usually administered via an intraperitoneal (i.p.) route, that will be not reproducible in clinical configurations. In this study, we characterized the distribution of chimeric αDEC205 or αDCIR2 mAbs via an intradermal (i.d.) course, compared the elicited humoral protected answers, and evaluated the protection of this possible immunization strategy under preclinical circumstances. As a model antigen, we used typ
Like
Comment
Share
